APITOPE TO PRESENT AT THE “THERAPEUTIC & PREVENTATIVE VACCINES FOR AUTOIMMUNE DISEASES: SCIENTIFIC & COMMERCIAL OPPORTUNITIES” SYMPOSIUM ON

9 JANUARY 2011, 2.45PM (PST)Bristol, UK / Hasselt, Belgium – 7th January 2011: Apitope International N.V., the biopharmaceutical company developing peptide therapies for autoimmune diseases, is pleased to announce that Dr. Keith Martin, CEO, will provide an update on Apitope (antigen processing independent epitope autoimmune vaccines) at the symposium on “Therapeutic & Preventative Vaccines for Autoimmune Diseases: Scientific & Commercial Opportunities”, sponsored by the Juvenile Diabetes Research Foundation and Fast Forward, LLC.

Dr. Martin will present at the Hilton San Francisco, Union Square, at 2.45pm (PST) on Sunday, 9 January 2011, prior to the J.P. Morgan Healthcare Conference.

The symposium will feature leading researchers and experts on autoimmune vaccines, presenting the latest scientific and technological knowledge and insight into this emerging field.

For further information:

Apitope International N.V.
Dr. Keith Martin, CEO
+44 (0)117 920 0062
keith.martin@apitope.com

Capital MSL
Mary Clark, Head of Life Sciences
+44 20 7307 5330
mary.clark@capitalmsl.com